FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/05/018946 [Registered on: 06/05/2019] Trial Registered Prospectively
Last Modified On: 03/05/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani
Other (Specify) [Hijamah (Cupping)]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Treatment Of Sciatica by Hijamah(cupping) therapy 
Scientific Title of Study   "A Randomized Controlled clinical Study To Evaluate The Efficacy Of Hijamah Bil Shart in Irq-un-Nasa (Sciatica)" 
Trial Acronym  Sciatica 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mohd Yaqoob 
Designation  MD Scholar 
Affiliation  JAMIA HAMDARD 
Address  Dept.Of Moalejat, School Of Unani Medical Education And Research, Jamia Hamdard New Delhi
Majeedia Unani Hospita Jamia Hamdard Hamdard Nagar New Delhi
South
DELHI
110062
India 
Phone  9671610426  
Fax    
Email  yaqoobmdunani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrMdWasi Akhtar 
Designation  Assistant Professor 
Affiliation  Jamia Hamdard 
Address  Dept.Of Moalejat School Of Unani Medical Education And Research Jamia Hamdard New Delhi
Majeedia Unani Hospita Jamia Hamdard Hamdard Nagar New Delhi
South
DELHI
110062
India 
Phone  9027570265  
Fax    
Email  drwasiakhtar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Yasmeen Shamsi 
Designation  Professor 
Affiliation  JAMIA HAMDARD 
Address  Head Of Dept.Of Moalejat School Of Unani Medical Education And Research Jamia Hamdard New Delhi
Majeedia Unani Hospita Jamia Hamdard Hamdard Nagar New Delhi
South
DELHI
110062
India 
Phone  8750040776  
Fax    
Email  yshamsi@jamiahamdard.ac.in  
 
Source of Monetary or Material Support  
Jamia Hamdard Hamdard Nagar New Delhi PIN-110062  
 
Primary Sponsor  
Name  Jamia Hamdard  
Address  Hamdard Nagar New Delhi PIN-110062  
Type of Sponsor  Other [University] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mohd Yaqoob   Majeedia Unani Hospital  Majeedia Unani Hospital School of Unani Medical Education and Research Jamia Hamdard New Delhi-110062
South
DELHI 
9671610426

yaqoobmdunani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Jamia Hamdard Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G55||Nerve root and plexus compressionsin diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Hijamah (wet cupping/ cupping with scarification)  Group A: Hijamah at buttock and thigh, in 3 sessions at 15 days interval 
Comparator Agent  Hijamah (wet cupping/ cupping with scarification)  Group B: Hijamah at calf muscle and ankle, in 3 sessions at 15 days interval 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details 
Already diagnosed patients of sciatica presenting with all or some of the following signs and symptoms
Unilateral leg pain greater than low back pain radiating towards leg/ foot/toes
Positive straight-leg-raising sign
Numbness and/ or tingling sensation in the same distribution
Pain intensity score of 30 -60 mm on a 100-mm visual analog scale (VAS)
Willingness to accept wet cupping intervention
 
 
ExclusionCriteria 
Details  Pregnant and lactating women.
Patients of previous back surgery/ lumbar spine surgery.
Patients of spinal tumors, gross/fixed developmental deformity, cauda equine or vertebral fracture
Patients of bleeding disorders
Patients of anaemia (Hb<10gm%)
Patients taking any other conservative treatment for sciatica (NSAIDS, corticosteroids, physiotherapy, acupuncture etc.)
Patients with malignancy or any liver, kidney or heart disease
Patients of of inherited neuropathy or neuropathy attributable to other causes like hypothyroidism, vitamin B12 deficiency etc.
Motor weakness/Muscle wasting
Patients suffering from Psychiatric disorders
HIV/AIDS, HCV and HBsAg positive patients
History of stroke, severe hypertension and uncontrolled diabetes mellitus
Unwilling to participate in the study 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in pain due to sciatica  0 day, 42 day 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in Disability and Quality of life  0 day, 42 day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   06/05/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   As per Jamia Hamdard guidelines 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This proposed open, randomized, prospective clinical study will be conducted on the diagnosed patients of Sciatica according to defined inclusion and exclusion criteria. 30 patients in group A and 30 patients in group B will allocated randomly. Hijamah at Warik and Fakhiz will be done in group A patients, whereas Hijamah at Saaq and Kaab will be done in group B patients on Day 0, Day 14 and Day 28. The assessment will be done on 0 day, 14th day, 28th day and 42nd day for improvement in pain, disability and quality of life. This study will validate the efficacy of Hijamah therapy in the management of Sciatica and will compare the efficacy as per the sites of Hijamah.  
Close